Home About us Reports Charts News Custom Company Scan  
Report Charts News
Title Content
Life Sciences
  Metals & Minerals
Public Sector
  Finance Service
  Real Estate
Technology And Media

Tel: 0086-10-82600828
Fax: 0086-10-82601570

  Fosun Pharma Buys 70% of Jinzhou Ahon Pharma for $219 Million
CreateTime:2011-09-14 Editor:lile
Text Size:       

Shanghai Fosun Pharmaceutical (Group) (600196.SH) will pay up to $219 million to acquire a 70% stake in Jinzhou Ahon Pharmaceutical Co. Shanghai Fosun said the acquisition will make its drug portfolio more competitive, especially in Ahon’s core strengths of the cardiovascular and central nervous system sectors.

Fosun Pharma also announced it will form a generic drug JV with Lonza Group of Switzerland, backed by $15.6 million in capital. The JV will take advantage of the strengths of each parent: Lonza in APIs and intermediates; Fosun in finishing and China distribution. The JV will be owned equally by the two partners.


Related Reports
China Animal Vaccine Industry Report, 2019-2025
China Blood Product Industry Report, 2020-2026
China Vacuum Blood Collection Device Industry Report, 2019-2025
China Human Vaccine Industry Report, 2019-2025
China Independent Clinical Laboratory Industry Report, 2019-2025
2005-2021 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1